Connect with us

Headlines

Visus Therapeutics Raises $36M in Financing

The company is developing a once-daily eye drop to correct for presbyopia.

mm

Published

on

SEATTLE — Visus Therapeutics Inc. announced the close of $36 million in financing.

Proceeds from the Series A preferred stock financing will be used to advance the clinical development program for the company’s lead asset, Brimochol, an investigational drug designed to be a once-daily eye drop to correct for the loss of near vision associated with presbyopia.

Participating in the round were Johnson & Johnson Innovation – JJDC Inc., RTW Investments LP and Wille AG, along with existing shareholders.

“We are committed to delivering on the promise of introducing a transformative solution to the current treatment landscape for presbyopia,” said Ben Bergo, co-founder and CEO of Visus. “Through our Series A financing and with the support of our seasoned health care investors, Visus is well positioned to rapidly progress our clinical development program for BRIMOCHOL.”

Tony Nguyen, managing director at RTW Investments, has been appointed to Visus’s board of directors.

Nguyen said: “Visus’ experienced leadership team has a successful track record of eye care drug development. This gives us great confidence that the Visus team can develop therapies that will make a life-changing difference for people living with presbyopia. Visus’ highly differentiated therapeutic approach to presbyopia treatment has the potential to be a significant step forward in this emerging category. We look forward to supporting the Visus team as they advance the clinical development program for BRIMOCHOL.”

Advertisement

SPONSORED VIDEO

Meet the Next Generation of Smart Glasses

Ray-Ban Meta is now available with a full range of lenses, as a complete pair or edged lens. Prescription orders eligible through select insurance providers, including Eyemed and private pay. The Ray-Ban Meta collection combines iconic design with cutting-edge technology. Capture life’s best moments and livestream to Facebook and Instagram with an upgraded 12 MP camera and five-mic system. Stay connected with hands-free calls and messages. Listen to your favorite tracks through built-in speakers. Spark your creativity, get information and control your glasses with your voice – powered by Meta AI. All while keeping your phone in your pocket. For more information, visit here.

Promoted Headlines

Advertisement

Advertisement

Subscribe

INVISIONMAG.COM
BULLETINS

Get the most important news and business ideas for eyecare professionals every weekday from INVISION.

Advertisement

Advertisement

Most Popular